January 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreNovember 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreMarch 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreNovember 01, 2025
According to market projections, the global biological inactivated vaccine market, valued at USD 0.95 billion in 2024, is anticipated to reach USD 1.57 billion by 2034, growing at a CAGR of 5.14% over the next decade.The rising prevalence of infectious disorders and the growing research and development activities bolster market growth. The presen...
November 01, 2025
Based on market forecasts, the originator drug sector will expand from USD 24.54 billion in 2024 to USD 50.05 billion by 2034, experiencing a CAGR of 7.44%.The originator market is growing due to rising research in drug development. North America’s dominance is due to the presence of a strong pharmaceutical industry....
November 01, 2025
Market insights predict, the nicotine oral spray industry is expected to grow from USD 140 million in 2024 to USD 301.28 million by 2034, driven by a CAGR of 7.94%. The nicotine oral spray market is expanding due to growing health awareness, as well as due to its convenience and portability. Europe led the market due to the growing innovations....
November 01, 2025
Projections indicate that, the global HPMC capsules market will increase from USD 0.5 billion in 2024 to USD 1.25 billion by 2034, experiencing a CAGR of 9.44% over the next 10 years.The market is growing due to rising demand for plant-based, gelatin-free alternatives. Increasing use in pharmaceuticals and nutraceuticals for moisture-sensitive an...
November 01, 2025
Due to the increasing burden of diverse cancer cases and demand for advanced chemotherapy drugs and services, the global market is expanding. The presence of advanced healthcare infrastructure and the growing demand for customized cancer care are driving North America....
November 01, 2025
According to market projections, the CDK4/6 inhibitors sector is expected to grow from USD 11.38 billion in 2024 to USD 46.96 billion by 2034, reflecting a CAGR of 15.34%. The rising prevalence of cancer and growing research and development activities drive the global market. The availability of a state-of-the-art R&D infrastructure and the p...
November 01, 2025
Market insights predict the global radionuclide drug conjugates (RDC) industry will increase from USD 3.24 billion in 2024 to USD 8.87 billion by 2034, achieving a CAGR of 10.54%. The global radionuclide drug conjugates (RDC) market is growing strongly due to the growing cases of genetic disorders. North America is dominating due to technological...
November 01, 2025
According to market projections, the radiation-induced dermatitis drug sector is expected to grow from USD 510 million in 2024 to USD 729.2 million by 2034, reflecting a CAGR of 3.64%. The growing need for radiation therapy and the increasing development of biologics bolster market growth. North America led the global market owing to the robust hea...
November 01, 2025
Projections indicate that, the global hematologic malignancies treatment market increased from USD 67.32 billion in 2024 to USD 139.13 billion by 2034, experiencing a CAGR of 7.61% over the next 10 years.The global rise in the elderly population, who are more prone to blood cancers, is fueling the growth of the market. ...
November 01, 2025
Market insights predict the global cell and gene therapy clinical trials industry will increase from USD 10.8 billion in 2024 to USD 45.31 billion by 2034, achieving a CAGR of 15.43%. Advancements in technologies such as gene editing, CAR-T therapy, and CRISPR-Cas9 have enabled the healthcare sector to address and fulfill the unmet medical needs ...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com